Payer Notebook: AHIP takes issue with proposed rule giving coverage pathway for FDA-approved breakthrough devices

Healthcare Finance: America's Health Insurance Plans this week submitted comments to a Centers for Medicare and Medicaid Services' proposed rule on Medicare Coverage of Innovative Technology and Definition of "reasonable and necessary." The proposed rule would establish a new Medicare coverage pathway for Food and Drug Administration-approved breakthrough devices under which national Medicare coverage for both traditional fee-for-service Medicare and Medicare Advantage would begin on the same day as a breakthrough device receives FDA approval, and would last up to four years.

Read article

Share

i360Gov Newsletters

The most significant government policy, business, and technology news and analysis delivered to your inbox.

Subscribe Now

Trending